|
Bortezomib, lenalidomide, and dexamethasone (VRd) ± daratumumab (DARA) in patients (pts) with transplant-eligible (TE) newly diagnosed multiple myeloma (NDMM): A multicenter, randomized, phase III study (PERSEUS). |
|
|
|
Consulting or Advisory Role - Celgene |
|
|
Honoraria - Amgen; Celgene; Janssen |
Consulting or Advisory Role - Amgen; Celgene; Janssen |
Travel, Accommodations, Expenses - Amgen; Celgene |
|
|
No Relationships to Disclose |
|
|
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi |
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Mundipharma; Novartis; Sanofi |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen |
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen |
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen |
|
|
Honoraria - Amgen; Celgene; Janssen; Takeda |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda |
|
|
Honoraria - Amgen; Celgene; Janssen; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda |
Research Funding - Celgene; Janssen |
|
|
Honoraria - Abbvie; Amgen; Celgene; Janssen; SERVIER; Takeda |
Consulting or Advisory Role - Abbvie; Celgene; Janssen; SERVIER |
Speakers' Bureau - Celgene; Janssen; Takeda |
Research Funding - Celgene; Janssen; Takeda |
|
|
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; PharmaMar; Takeda |
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; PharmaMar; Takeda |
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda |
|
|
Stock and Other Ownership Interests - Cura8; Nordic Nanovector |
Honoraria - Amgen; Celgene; Janssen; Novartis; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; MSD; Oncopeptides; Takeda |
|
|
|
No Relationships to Disclose |
|
|
|
|
|
|
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - GlaxoSmithKline; Johnson & Johnson; Sanofi |
Travel, Accommodations, Expenses - Janssen Research & Development |
|
|
|
|
|
|
Stock and Other Ownership Interests - Janssen |
|
|
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda |